Ibrutinib/Imbruvia and low antibody: The NYTimes... - CLL Support

CLL Support

22,532 members38,709 posts

Ibrutinib/Imbruvia and low antibody

prichman profile image
5 Replies

The NYTimes article cited Imbruvica and low antibody reading, but it's information was sparse. Does Imbruvica reduce response or do people who need Imbruvica have lower responses? Does anyone know?

Written by
prichman profile image
prichman
To view profiles and participate in discussions please or .
Read more about...
5 Replies
annmcgowan profile image
annmcgowan

Hi I don’t think ibrutinib impacts antibody reaction. It is more likely the CLL. I find the whole antibody testing issue baffling. People are going for testing but my haematologist advised me not to. He says they do not know how to analyse the tests well enough yet so we can’t rely on a positive or negative result. Neither do the tests indicate T cell responses.

So far I have followed his advice but am intersected in other peoples opinion.

Ann

AussieNeil profile image
AussieNeilAdministrator

All CLL treatments reduce B-lymphocyte counts, both CLL cells and healthy B-lymphocytes. You need new, healthy B-lymphocytes to respond to vaccinations and mature into plasma cells which make antibodies. Imbruvica/Ibrutinib doesn't have as strong an impact on your immunity as some treatments. The anti-CD20 monoclonal antibody treatments (Rituximab, Obinutuzumab, Ofatumumab, etc), keep on killing off B- lymphocytes for up to a year after your last infusion. Ibrutinib seems to improve T-lymphocyte function, which is also important in vaccination response.

Neil

cajunjeff profile image
cajunjeff

I think the answer is that being on ibrutinib, or any other btk inhibitor, suppresses B cells necessary for creating an immune response. Therefore, on average, people on btk therapy do not show as robust an antibody response to covid vaccines as others do.

Doctors nevertheless recommend people on btk inhibitors get vaccinated for covid because the mechanism of how the vaccines help is not fully known. Just because one has a low antibody response to the vaccine does not mean the vaccine is not providing protection against severe disease from covid.

I do not think, as a matter of course, doctors are advising people to pause btk treatment just to get the vaccine though.

Some people conclude lack of antibody response to a Covid antibody test means no protection has been provided by the vaccine, but that might not be the case. We will not know for sure until we see how many people who have Cll and have been vaccinated end up getting covid and among those, how many have severe cases.

prichman profile image
prichman in reply to cajunjeff

Helpful. My Dr said the Vaccine clinical trials did not have a CLL cohort, but did have high blood pressure and heart patients. So data is still lacking, as you say. Somehow, in my imagination I've thought that Imbruvica suppressed bad B-cells, but left good B-cells to do their job. Apparently, not a good as my (normal) wife's.

lankisterguy profile image
lankisterguyVolunteer

We had a similar discussion yesterday- some of the replies might be useful: healthunlocked.com/cllsuppo...

Len

You may also like...

Ibrutinib and low platelet

decreased and doktor stopped ibrutinib for test. Does anyone have any experience with this? Can it...

Ibrutinib and antibodies

taking it prior to their jabs. Does anyone know if that helped develop antibodies and is something...

low dose antibiotics/life after Ibrutinib?

person they mentioned that it was possible to be on low dose antibiotics for a long time without...

(Imbruvica), Ibrutinib, To live or to die

Turkey and was prescribed Imbruvica from Janssen company. Since he does not have insurance, he...

Ibrutinib

had a nasty viral infection. Does anyone else take this and how long have they been off work?